Viewing Study NCT06518005


Ignite Creation Date: 2025-12-25 @ 3:25 AM
Ignite Modification Date: 2026-01-08 @ 10:04 AM
Study NCT ID: NCT06518005
Status: RECRUITING
Last Update Posted: 2024-12-03
First Post: 2024-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
Sponsor: Genethon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module